Cargando…
Copy‐number intratumor heterogeneity as high‐risk feature of stage II colon cancer(†)
Overall, the prognosis of patients suffering from stage II colon cancer is relatively favorable. However, a proportion of patients develop a recurrence following surgery. Clinical and histopathological properties that identify high‐risk patients are of limited value and better biomarkers are urgentl...
Autores principales: | van den Bosch, Tom, Miedema, Daniël M, Vermeulen, Louis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544760/ https://www.ncbi.nlm.nih.gov/pubmed/35470895 http://dx.doi.org/10.1002/path.5919 |
Ejemplares similares
-
Predicting survival of cancer patients by chromosomal copy number heterogeneity
por: Van Den Bosch, Tom, et al.
Publicado: (2021) -
Copy‐number intratumor heterogeneity increases the risk of relapse in chemotherapy‐naive stage II colon cancer
por: Lahoz, Sara, et al.
Publicado: (2022) -
Chromosomal copy number heterogeneity predicts survival rates across cancers
por: van Dijk, Erik, et al.
Publicado: (2021) -
Metabolomics reveals intratumor heterogeneity – Implications for precision medicine
por: Liu, Xiaojing, et al.
Publicado: (2017) -
An overview of mutational and copy number signatures in human cancer
por: Steele, Christopher D, et al.
Publicado: (2022)